The agency is seeking solutions to rapidly address public health needs related to the pandemic.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Having the ability to assess vital signs in real time could be the future of monitoring the health of travelers to help prevent outbreaks.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
Smart process automation promises to cut complexity and transform product traceability in the medical device industry. However, its potential relies 100% cent on having good, reliable data on which to draw.
Artificial intelligence and machine learning are proving to be meaningful weapons in our arsenal during the coronavirus crisis.
From artificial intelligence to autonomous sterilization robots to drones, emerging technologies are playing a strong role in combating COVID-19.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.